Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2019 Dec 14;47(4):895–906. doi: 10.1007/s00259-019-04601-3

Fig. 6: Changes in CgA with PRRT (n=112).

Fig. 6:

6A. Dynamics of the biomarker and treatment. Responders were not associated with a significant decrease in CgA levels following therapy. Similarly, no significant differences were identified in CgA levels in non-responders.

6B. Mean changes in CgA levels (between follow-up and baseline) in responders (n=76) compared to non-responders (n=36). CgA levels were increased and mean levels were not significantly different between responders and non-responders.